SCHEMBL418147

SCHEMBL418147

O=C1COOC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5845578 0.70
SCHEMBL9580258 0.69
SCHEMBL702562 0.67
SCHEMBL3257468 0.65
SCHEMBL3370693 0.63
SCHEMBL13661891 0.55
SCHEMBL1738884 0.55
SCHEMBL442819 0.55
SCHEMBL11913224 0.53
SCHEMBL4594727 0.53 TSHR (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3643401-A1 COBALT CATALYST COMPRISING A SUPPORT WITH A MIXED OXIDE PHASE CONTAINING COBALT AND/OR NICKEL PREPARED FROM A DILACTONE COMPOUND IFP Energies nouvelles (FR) 2020-04-29 EP claimed
CN-1960982-A Method for producing 1,3-dioxolan-4,6-dione compound FUJI PHOTO FILM CO LTD (JP) 2007-05-09 CN claimed
EP-3643401-B1 COBALT CATALYST COMPRISING A SUPPORT WITH A MIXED OXIDE PHASE CONTAINING COBALT AND/OR NICKEL PREPARED FROM A DILACTONE COMPOUND IFP ENERGIES NOW (FR) 2023-03-15 EP disclosed
US-11235312-B2 Cobalt catalyst comprising a support comprising a mixed oxide phase including cobalt and/or nickel produced from a dilactone compound IFP Energies Nouvelles (FR) 2022-02-01 US disclosed
CN-113557238-A Lithium borate compound, additive for lithium secondary battery, nonaqueous electrolyte for lithium secondary battery, lithium secondary battery precursor, and method for producing lithium secondary battery 三井化学株式会社 2021-10-26 CN disclosed
CN-112004928-A Oligonucleotide compositions and methods of use thereof 波涛生命科学有限公司 2020-11-27 CN disclosed
CN-104661664-B Chiral control 波涛生命科学有限公司 2020-07-03 CN disclosed
CN-111372942-A β -catenin function modulating agents and methods thereof 弗格制药有限公司 2020-07-03 CN disclosed
US-20200129966-A1 COBALT CATALYST COMPRISING A SUPPORT COMPRISING A MIXED OXIDE PHASE INCLUDING COBALT AND/OR NICKEL PRODUCED FROM A DILACTONE COMPOUND IFP Energies Nouvelles (FR) 2020-04-30 US disclosed
EP-3643401-A1 COBALT CATALYST COMPRISING A SUPPORT WITH A MIXED OXIDE PHASE CONTAINING COBALT AND/OR NICKEL PREPARED FROM A DILACTONE COMPOUND IFP Energies nouvelles (FR) 2020-04-29 EP disclosed
US-20150361063-A1 TREATMENT OF AMYLOIDOSIS BY COMPOUNDS THAT REGULATE RETROMER STABILIZATION THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2015-12-17 US disclosed
WO-2002010096-A1 KINETIC RESOLUTIONS OF CHIRAL 2- AND 3-SUBSTITUTED CARBOXYLIC ACIDS BRANDEIS UNIVERSITY (US) 2002-02-07 WO disclosed
US-6331570-B1 PREVENTION OF SPONTANEOUS SQUAMOUS CELL CARCINOMA IN IMMUNOCOMPROMISED HUMAN TRANSPLANT PATIENTS BRISTOL-MYERS SQUIBB COMPANY 2001-12-18 US disclosed
EP-1115395-A1 ACTIVE ENANTIOMER OF RARgamma-SPECIFIC AGONIST BRISTOL-MYERS SQUIBB COMPANY (US) 2001-07-18 EP disclosed
US-6200997-B1 CYCLIZATION TO GIVE OXAZOLIDINEDIONES AND TRIAZOLIDINEDIONES BASF AKTIENGESELLSCHAFT (DE) 2001-03-13 US disclosed
WO-2000016769-A1 ACTIVE ENANTIOMER OF RARη-SPECIFIC AGONIST BRISTOL-MYERS SQUIBB COMPANY (US) 2000-03-30 WO disclosed
WO-1998029396-A1 HETEROCYCLIC AROMATIC ANION SALTS, AND THEIR USES AS IONIC CONDUCTING MATERIALS HYDRO-QUEBEC (CA) 1998-07-09 WO disclosed
EP-0219070-B1 A PROCESS FOR PREPARING N-GLYCOLYLNEURAMINIC ACID DERIVATIVES MECT CORPORATION (JP) 1989-06-21 EP disclosed
US-4774326-A ANTITUMOR ANTIGENS, AMIDATION WITH GLYCOLIC ACID MECT CORPORATION (JP) 1988-09-27 US disclosed
EP-0219070-A2 A process for preparing N-glycolylneuraminic acid derivatives MECT CORPORATION (JP) 1987-04-22 EP disclosed